M. C. Pontelli

This study shows bromhexine hydrochloride inhibits SARS-CoV-2 infection in vitro by targeting TMPRSS2, reducing viral entry and progeny without direct virucidal activity.

This paper develops a chimeric VSV expressing OROV glycoproteins that elicits neutralizing antibodies and reduces viral infection in mice.

This study shows that HRSV infection of CD4+ T cells is inefficient compared to epithelial cells, with reduced fusion, lower protein production, and altered viral trafficking.

This study investigates SARS-CoV-2 infection of human lymphomononuclear cells in vitro and in vivo, finding that monocytes, B cells, and T cells are susceptible to infection and viral replication.